Close Menu

Point-of-Care Testing

News on technologies and applications for point-of-care testing.

The firm said that its point-of-care antigen testing platform uses high-frequency bulk acoustic wave sensors to detect SARS-CoV-2 at low limits of detection.

Building on recently published NIH-funded work on rapid antigen testing, the CDC and NIH have launched a study to evaluating community-wide home testing.

The firm said its rapid antigen test provided 97.3 percent sensitivity and 99.6 percent specificity in clinical studies, and it is developing a saliva-based version.

Lucira Health's at-home molecular test received Emergency Use Authorization in November for prescription use.

The technology underlying the test was developed by Dutch firm Minicare, which was acquired by Siemens in 2019.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.